Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Hypertension ; 76(1): 176-183, 2020 07.
Article in English | MEDLINE | ID: mdl-32450740

ABSTRACT

The sFlt-1 (soluble fms-like tyrosine kinase-1), PlGF (placental growth factor), and their ratio are useful for predicting delivery because of preeclampsia in singleton pregnancies. Evidence on the utility of sFlt-1/PlGF ratio in twin pregnancies is lacking. We aimed to evaluate the predictive value of sFlt-1/PlGF ratio for delivery because of preeclampsia in twins. A retrospective data analysis of 164 twin pregnancies with suspected preeclampsia was performed. The sFlt-1/PlGF ratio, which was known to clinicians, was significantly higher in women who delivered within 1 and 2 weeks compared with those who did not (median: 98.9 and 84.2 versus 23.5 pg/mL, respectively; P<0.001). The area under the curve values sFlt-1/PlGF ratio levels were 0.88 (95% CI, 0.83-0.84) and 0.88 (95% CI, 0.83-0.93) for predicting delivery because of preeclampsia within 1 and 2 weeks of blood sampling, respectively. The predictive accuracy of sFlt-1/PlGF was independent of gestational age at sampling and chorionicity (P>0.100 for interaction). The area under the curve values of sFlt-1/PlGF were significantly higher than for PlGF alone (mean 0.88 and 0.88 versus 0.81 and 0.80) for predicting delivery because of preeclampsia within 1 and 2 weeks of blood sampling (P=0.055 and 0.001, respectively). sFlt-1/PlGF ratio lower than 38 was able to rule-out delivery within 1 and 2 weeks with a negative predictive value of 98.8% and 96.4% for delivery because of preeclampsia within 1 and 2 weeks, respectively. A cutoff of 38 is applicable for ruling out delivery because of preeclampsia in twin pregnancies.


Subject(s)
Delivery, Obstetric/statistics & numerical data , Membrane Proteins/blood , Neovascularization, Physiologic , Pre-Eclampsia/blood , Pregnancy, Twin/blood , Vascular Endothelial Growth Factor Receptor-1/blood , Abruptio Placentae/etiology , Adult , Antihypertensive Agents/therapeutic use , Area Under Curve , Biomarkers/blood , Databases, Factual , Dyspnea/etiology , Female , Gestational Age , HELLP Syndrome/etiology , Humans , Infant, Newborn , Pre-Eclampsia/drug therapy , Pregnancy , Pregnancy Complications/blood , Pregnancy Outcome , Prognosis , Retrospective Studies , Thrombocytopenia/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...